BioPharma
19 February, 2025 | Wednesday | News
South Korea’s Celltrion Secures EU Approval for Three Biosimilar Products, Expanding Its Portfolio to 11 by 2025
Celltrion gains simultaneous regulatory approval of two monoclonal antibody biosimilars across three treatments – Eydenzelt® (aflibercept), Stoboclo® and Osenvelt® (deno...
Lab
12 February, 2025 | Wednesday | News
PHC Corporation Partners with CCRM to Advance T-Cell Expansion for Cell and Gene Therapies
PHC Corporation has signed a Master Collaboration Agreement with CCRM, a global leader in regenerative medicine and biomanufacturing, to jointly develop primary T-cell expansion culture processes aimed at accel...
BioTech
13 February, 2025 | Thursday | News
Thermo Fisher Scientific Introduces Invitrogen™ EVOS™ S1000 for Advanced Spatial Tissue Imaging
Thermo Fisher Scientific Inc., the world leader in serving science, introduced the Invitrogen™ EVOS™ S1000 Spatial Imaging System. This advanced system addresses the limitations of current fluoresce...
Contract Services
05 February, 2025 | Wednesday | News
Eleva and 3PBIOVIAN Forge Strategic Alliance to Advance Clinical-Grade Biologics Production
3PBIOVIAN provides production capacity for clinical-grade material for current and future development programs including Eleva’s proprietary Factor H (CPV-104) program, which is expected to enter a firs...
Consumer Health
19 February, 2025 | Wednesday | Expert Insight
ORA’s Hybrid Model Reshapes Obesity Care: Dr. Ben Ng on Bridging Telehealth and In-Person Treatment
With obesity-related chronic diseases on the rise in Singapore, ORA Group has introduced a pioneering hybrid weight management model, blending telehealth with in-person consultations for a perso...
White Paper
07 January, 2025 | Tuesday | News
2025 Pharma and Medical Device Trends for Manufacturing Leaders
Product Spot Light
12 February, 2025 | Wednesday | News
PHC Corporation Partners with CCRM to Advance T-Cell Expansion for Cell and Gene Therapies
Premium Article
03 February, 2025 | Monday | Product Spotlight
Say goodbye to the cable tie and hello to the BioTitan Retention Device—zero leaks reported!
Bio Invest
17 February, 2025 | Monday | News
Bambusa Therapeutics Closes $90 Million Series A to Advance Bispecific Antibody Pipeline for Immunological and Inflammatory Disorders
Biopharma APAC Infomercial
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
